Differential effect of canagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, on slow and fast skeletal muscles from nondiabetic mice

Medicine and Dentistry

• Slow Muscle 100%
• Fast Muscle 100%
• Canagliflozin 50%
• Sodium Glucose Cotransporter 2 Inhibitor 40%
• Sodium Glucose Cotransporter 2 40%
• Metabolite 30%
• Skeletal Muscle 20%
• Adenosine Triphosphate 20%
• Muscle Function 20%
• Food Intake 20%
• Gene Expression 10%
• Inpatient 10%
• Introspection 10%
• Amino Acid 10%
• Glucose Metabolism 10%
• Patient with Diabetes 10%
• Fatty Acid 10%
• Feeding 10%
• Sarcopenia 10%
• Mouse Study 10%
• Metabolome Analysis 10%

Neuroscience

• Canagliflozin 50%
• Skeletal Muscle 20%
• Adenosine Triphosphate 20%
• Glucose 10%
• Feeding Behavior 10%
• Gene Expression 10%
• Amino Acids 10%
• Diabetes 10%
• Metabolome 10%
• Free Fatty Acids 10%